Plain-English translation of NCT07710768 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This research study is testing a new medication called to see if it is safe and works well when taken together with other common medicines. Researchers want to understand how affects the way your body processes certain medications — specifically caffeine, a blood thinner called warfarin, and a sedative called midazolam. This helps doctors know if it's safe to use this new treatment alongside medicines you might already be taking.
Before a new medication can be widely prescribed, researchers need to make sure it doesn't cause dangerous interactions with other drugs people commonly take. This study fills that gap by testing the medication in people with excess body weight to understand these interactions early on.
You likely qualify if…
You likely don't qualify if…
You would receive injections of the new medication under your skin, with gradually increasing doses throughout the study. At specific visits, you would also take a small cocktail of three common medications (caffeine, warfarin, and a sedative) so researchers can measure how the new treatment affects their levels in your bloodstream. The study follows a crossover design, meaning you'll likely receive both the new medication and the test drugs at different timepoints, allowing doctors to compare how your body responds.
AI-generated summary from trial data · Sep 5, 2026 · Not medical advice
United States